Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Muñoz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet. 2002;360:1921–6.

Article  PubMed  Google Scholar 

Wyles DL. Antiretroviral effects on HBV/HIV co-infection and the natural history of liver disease. Clin Liver Dis. 2019;23:473–86.

Article  PubMed  Google Scholar 

Sherman KE, Thomas DL. HIV and liver disease: a comprehensive update. Top Antivir Med. 2022;30:547–58.

PubMed  PubMed Central  Google Scholar 

Corcorran MA, Kim N. Chronic hepatitis B and HIV coinfection. Top Antivir Med. 2023;31:14–22.

PubMed  PubMed Central  Google Scholar 

Terrault NA, Lok ASF, McMahon BJ, Chang K, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.

Article  PubMed  Google Scholar 

Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23:273–85.

Article  PubMed  Google Scholar 

Mannan R, Misra V, Misra SP, Singh PA, Dwivedi M. A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis. J Clin Diagn Res. 2014;8:FC08-12.

PubMed  PubMed Central  Google Scholar 

Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, Diseases AA for the S of L. Liver biopsy. Hepatology. 2009;49:1017–44.

Article  PubMed  Google Scholar 

Leroy V, Chevaliez S, Decraecker M, et al. Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus. Clin Res Hepatol Gastroenterol. 2022;46:101773.

Article  CAS  PubMed  Google Scholar 

Jachs M, Hartl L, Bauer D, Simbrunner B, Stättermayer AF, Strassl R, et al. Long-term outcome of HBV-infected patients with clinically significant portal hypertension achieving viral suppression. J Pers Med. 2022;12(2):239.

Article  PubMed  PubMed Central  Google Scholar 

Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468–75.

Article  CAS  PubMed  Google Scholar 

Xu Y, Zhang Y-G, Wang X, Qi W-Q, Qin S-Y, Liu Z-H, et al. Long-term antiviral efficacy of Entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol. 2015;21:7869–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sterling RK, King WC, Khalili M, et al. A prospective study evaluating changes in histology, clinical and virologic outcomes in HBV-HIV co‐infected adults in North America. Hepatology. 2021;74:1174–89.

Article  CAS  PubMed  Google Scholar 

Boyd A, Bottero J, Miailhes P, Lascoux-Combe C, Rougier H, Girard P, Serfaty L, Lacombe K. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with Tenofovir disoproxil fumarate in france: a prospective cohort study. J Int AIDS Soc. 2017;20:21426.

Article  PubMed  PubMed Central  Google Scholar 

Vinikoor MJ, Sinkala E, Chilengi R, et al. Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia. Clin Infect Dis. 2017;64:1343–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang R, Gui X, Ke H, Xiong Y, Gao S. Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection. AIDS Res Ther. 2021;18:98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohr R, Schierwagen R, Schwarze-Zander C, Boesecke C, Wasmuth J-C, Trebicka J, Rockstroh JK. Liver fibrosis in HIV patients receiving a modern cART. Medicine. 2015;94:e2127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sterling RK, King WC, Wahed AS, et al. Evaluating noninvasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV co-infected adults. Hepatology. 2020;71:411–21.

Article  CAS  PubMed  Google Scholar 

Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64:773–80.

Article  CAS  PubMed  Google Scholar 

Ghany MG, Buti M, Lampertico P, Lee HM, Faculty on behalf of the 2022 A-EH-HTEC. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV treatment endpoints conference. Hepatology. 2023;78:1654–73.

Article  PubMed  Google Scholar 

Kramvis A, Chang K-M, Dandri M, et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022;19:727–45.

Article  PubMed  PubMed Central  Google Scholar 

Boettler T, Gill US, Allweiss L, Pollicino T, Tavis JE, Zoulim F. Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection. JHEP Rep. 2022;4:100480.

Article  PubMed  PubMed Central  Google Scholar 

Testoni B, Suarez AAR, Battisti A, et al. Evaluation of the HBV liver reservoir with fine needle aspirates. JHEP Rep. 2023;5:100841.

Article  PubMed  PubMed Central  Google Scholar 

Gill US, Pallett LJ, Kennedy PTF, Maini MK. Liver sampling: a vital window into HBV pathogenesis on the path to functional cure. Gut. 2018;67:767.

CAS  PubMed  Google Scholar 

Gill US, Pallett LJ, Thomas N, Burton AR, Patel AA, Yona S, Kennedy PTF, Maini MK. Fine needle aspirates comprehensively sample intrahepatic immunity. Gut. 2019;68:1493–503.

Article  CAS  PubMed  Google Scholar 

Allweiss L, Testoni B, Yu M, et al. Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 2023;72:972–83.

Article  CAS  PubMed  Google Scholar 

Chen E-Q, Feng S, Wang M-L, Liang L-B, Zhou L-Y, Du L-Y, Yan L-B, Tao C-M, Tang H. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B. Sci Rep. 2017;7:173.

Article  PubMed  PubMed Central  Google Scholar 

Chuaypen N, Sriprapun M, Praianantathavorn K, Payungporn S, Wisedopas N, Poovorawan Y, et al. Kinetics of serum HBsAg and intrahepatic CccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg‐negative chronic hepatitis B. J Med Virol. 2017;89:130–8.

Article  CAS  PubMed  Google Scholar 

Kim SC, Wallin JJ, Ghosheh Y, et al. Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates. JHEP Rep. 2023;5:100817.

Article  PubMed  PubMed Central  Google Scholar 

Carey I, Gersch J, Wang B, Moigboi C, Kuhns M, Cloherty G, et al. Pregenomic HBV RNA and hepatitis B core-related antigen predict outcomes in hepatitis B e antigen–negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy. Hepatology. 2020;72:42–57.

Article  CAS  PubMed  Google Scholar 

Lisker-Melman M, Wahed AS, Ghany MG, et al. HBV transcription and translation persist despite viral suppression in HBV‐HIV co‐infected patients on antiretroviral therapy. Hepatology. 2023;77:594–605.

Article  PubMed  Google Scholar 

Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis. 1989;160:577–82.